Biotech POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS March 2, 2025
Food & Beverage Sucraid® (sacrosidase) Oral Solution. Free 4-Day Trial Now Available. The only FDA- approved therapy to treat CSID (Congenital Sucrase-Isomaltase Deficiency) March 2, 2025
Search
March 2, 2025
March 2, 2025
March 2, 2025
March 2, 2025
March 2, 2025
March 2, 2025
March 1, 2025
March 1, 2025
March 1, 2025
March 1, 2025
